COLORADO SPRINGS, Colo.,
Aug. 6, 2013 /PRNewswire/ -- The
X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company
specializing primarily in cannabinoid formulation-based health and
wellness solutions is excited to see expansion of its target market
into Uruguay. After jumping the
most difficult hurdle in the country's lower legislative body,
national legalization is expected to be signed into law in October.
This unprecedented national move is consistent with the rapid
opening of the cannabis and cannabinoid product and treatment
market worldwide, with legalization milestones being passed nearly
every week in Europe, the United States, and now South America. The Uruguayan law would allow
those 18 years of age and older to add themselves to a registry and
then obtain their medical marijuana from pharmacies. This would be
similar to laws adopted or under consideration in nearly two dozen
states in the U.S., as well as to laws in Canada and Europe.
Uruguayan President Jose Mujica
is in full support of the bill, as are various Latin American
leaders who are raising the legalization debate to a new level of
persuasion and rationality. Motivating factors for legalization
include reducing illegal drug trafficking and violence and creating
inexpensive and effective medical options for those living in
poverty.
Former Mexican President Vicente
Fox has voiced his support for legalization. In a recent
article, President Fox is quoted as saying, "Using military force
to fight cartels doesn't work . . . but legalization would." In an
interview with Wolf Blitzer on CNN
in May, President Fox said, "With [legalization], we will avoid the
violence…. We will control the criminals and reduce their income,
and at the same time, [a legal market] would become a transparent,
accountable business in the hands of businessmen."
"I could not agree more with former Mexican President
Vicente Fox and with current
Uruguayan President Jose Mujica.
After recent acceptance of medicinal cannabis in twenty states in
the U.S. and around the globe, it is encouraging -- and not
unexpected -- to see policy makers taking a pragmatic and
humanitarian approach to opening the medical cannabis market to
people with unmet needs. Here at X-Change Corporation, we work
relentlessly on supporting and expanding the development of the
markets for cannabinoids, especially in an economy under stress and
in which patients need effective, proven cannabinoid medicine,"
stated Robert Kane, X-Change Corp's
CFO and Sr. VP of Business Development.
About The X-Change Corporation
The X-Change Corporation is currently developing new natural
cannabinoid containing products based on innovative formulations to
utilize the unique and potent benefits of the cannabis and hemp
plants. Medicinal properties of cannabis and hemp have been known
and applied for thousands of years. With the aid of scientific
research, The X-Change Corporation is translating such knowledge
into development of effective cannabinoid formulation-based health
and wellness solutions as well as cosmeceutical, nutraceutical, and
food brands throughout the world. The Company's health and
wellness, nutritional, and cosmetics lines will address personal
needs and will evolve with the introduction of new formulations and
products, advancing the Company within the expanding
multibillion-dollar global market.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. X-Change Corp. does not undertake any duty nor does it
intend to update the results of these forward-looking
statements.
X-Change Corp.
President
Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595
Investment Inquiries:
Robert Kane
CFO, Sr Vp of Business Development
rkane@xchangecorp.com
+1.561.420.4824
SOURCE X-Change Corporation